DrugPatentWatch Database Preview
Litigation Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
» See Plans and Pricing
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
Docket | Start Trial | Date Filed | 2017-03-03 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 6,235,004; 6,268,343; 8,114,833; 8,846,618; 9,265,893; RE41,956 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.
Biologic Drugs cited in Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.
The biologic drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-06-26 | 61 | Report and Recommendations | ., 1:24-26 ("U.S. Pat. No. 6,235,004 [("the '004 patent")] discloses an injection device….S. Patent Nos. 6,268,343 ("the '343 patent"); 8,114,833 ("the '833 patent"…(EP '581 patent at 17), as do similar figures in the '004 patent, '004 patent, figs. 15-16…the '004 patent. '893 patent, 1:29-34 (citing Figs. 15-16 of the '004 patent) ("[T]he….S. Patent Nos. 8,114,833 ("the '833 patent"); 9,265,893 ("the '893 patent" | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |